Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 04 04:00PM ET
0.7810
Dollar change
-0.0115
Percentage change
-1.45
%
Index- P/E- EPS (ttm)-1.38 Insider Own4.51% Shs Outstand208.22M Perf Week-9.92%
Market Cap162.62M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float198.84M Perf Month3.95%
Income-249.68M PEG- EPS next Q-0.01 Inst Own41.90% Short Float8.80% Perf Quarter145.29%
Sales12.28M P/S13.24 EPS this Y68.83% Inst Trans-16.22% Short Ratio1.23 Perf Half Y39.17%
Book/sh0.11 P/B6.86 EPS next Y50.55% ROA-119.44% Short Interest17.50M Perf Year45.03%
Cash/sh0.13 P/C5.85 EPS next 5Y- ROE-194.05% 52W Range0.29 - 1.48 Perf YTD43.75%
Dividend Est.- P/FCF- EPS past 5Y-15.96% ROI-472.99% 52W High-47.23% Beta1.24
Dividend TTM- Quick Ratio1.03 Sales past 5Y17.84% Gross Margin-43.29% 52W Low168.29% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.03 EPS Y/Y TTM-16.34% Oper. Margin-1663.90% RSI (14)43.46 Volatility7.14% 9.34%
Employees405 Debt/Eq1.23 Sales Y/Y TTM-94.38% Profit Margin-2033.69% Recom2.12 Target Price3.80
Option/ShortYes / Yes LT Debt/Eq1.23 EPS Q/Q73.04% Payout- Rel Volume0.19 Prev Close0.79
Sales Surprise-94.83% EPS Surprise-22.70% Sales Q/Q-94.79% EarningsAug 06 AMC Avg Volume14.21M Price0.78
SMA20-8.35% SMA50-8.30% SMA20018.60% Trades Volume2,754,710 Change-1.45%
Date Action Analyst Rating Change Price Target Change
Nov-03-23Downgrade RBC Capital Mkts Outperform → Sector Perform $6 → $2
Apr-28-23Downgrade BofA Securities Neutral → Underperform $5 → $1.50
Feb-27-23Upgrade Wedbush Neutral → Outperform $16
Jan-06-23Downgrade BofA Securities Buy → Neutral $8 → $5
Jun-13-22Resumed Wedbush Neutral $5
May-04-21Initiated RBC Capital Mkts Outperform $22
Jan-07-21Resumed Guggenheim Neutral $16
Jan-06-21Initiated Stifel Hold $16
Dec-16-20Resumed H.C. Wainwright Buy $25
Sep-08-20Initiated BofA Securities Buy $20
Aug-07-24 01:24PM
04:32AM
Aug-06-24 05:35PM
04:37PM
04:01PM
08:11AM Loading…
08:11AM
08:05AM
Jul-30-24 04:15PM
Jul-24-24 06:55AM
May-12-24 08:28AM
May-10-24 03:58PM
May-09-24 08:58PM
05:25PM
04:23PM
04:01PM
10:46AM Loading…
10:46AM
08:05AM
May-02-24 04:15PM
Apr-22-24 04:35PM
Mar-22-24 08:05AM
Mar-14-24 07:23AM
Mar-13-24 08:21AM
08:05AM
08:01AM
Mar-12-24 06:30PM
Feb-12-24 08:05AM
Feb-05-24 06:01PM
Nov-03-23 05:03PM
Nov-02-23 08:15AM
Nov-01-23 07:05PM
04:13PM Loading…
04:13PM
04:01PM
Oct-26-23 10:02AM
Oct-25-23 04:15PM
Oct-24-23 02:01AM
Sep-20-23 04:15PM
Aug-25-23 01:38PM
Aug-08-23 05:30PM
04:26PM
04:01PM
Aug-01-23 04:15PM
Jul-20-23 08:05AM
Jul-19-23 07:08AM
Jul-17-23 08:05AM
Jun-29-23 08:05AM
Jun-28-23 09:20AM
Jun-14-23 08:16AM
May-22-23 08:05AM
May-18-23 07:04AM
May-16-23 08:00AM
May-02-23 04:30PM
06:03AM
Apr-26-23 05:28PM
Apr-25-23 02:39PM
Apr-21-23 04:58AM
Apr-19-23 04:15PM
Apr-17-23 07:38AM
Apr-16-23 06:30AM
Mar-23-23 06:09AM
Mar-21-23 09:35AM
Mar-20-23 12:25PM
Mar-10-23 09:35AM
Feb-25-23 08:26AM
Feb-23-23 05:36PM
11:57AM
Feb-22-23 05:25PM
04:01PM
03:01PM
09:35AM
Feb-21-23 09:01AM
Feb-16-23 10:01AM
Feb-13-23 09:55AM
Feb-10-23 11:01AM
Jan-30-23 07:10PM
Dec-06-22 06:02AM
Nov-09-22 05:31AM
Nov-03-22 05:55PM
04:01PM
Oct-27-22 04:15PM
Oct-14-22 09:49AM
Oct-12-22 08:55AM
03:01AM
Sep-23-22 12:02PM
Sep-18-22 09:11AM
Aug-30-22 08:50AM
06:00AM
Aug-29-22 09:55AM
Aug-12-22 09:55AM
Aug-04-22 05:45PM
04:01PM
Jul-28-22 04:15PM
Jul-21-22 08:05AM
Jul-18-22 09:21AM
Jun-07-22 08:55AM
Jun-01-22 04:30PM
May-08-22 08:09AM
May-05-22 05:45PM
04:01PM
May-04-22 06:35PM
May-02-22 04:30PM
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.